July 7, 2004
Running Time: 0:51:18
International aid organizations and governments should proceed immediately with the rollout of several major new programs to deliver HIV/AIDS care on a large scale in the developing world, while also determining ways to reduce the likelihood of treatment failure and drug resistance, says a new report from the Institute of Medicine of the National Academies. With substantial cuts in antiretroviral drug prices and an influx of billions of dollars in donations, the greatest obstacle now facing these large-scale initiatives is a critical shortage of qualified health care workers and support personnel in the resource-poor countries where the epidemic is most severe. This shortfall should be addressed through partnerships, technology transfer, and the mobilization of a Peace Corps-like "HIV/AIDS corps" of technical specialists, said the committee that wrote the report.
James Curran, M.D., M.P.H.,
Dean of the Rollins School of Public Health; Professor of Epidemiology; and Director of the Center for AIDS Research, Emory University, Atlanta and
Co-Chair, Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings.